Cargando…
Incident atrial fibrillation and adverse clinical outcomes during extended follow-up of participants recruited to the remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study
AIMS: Atrial fibrillation (AF) is an important risk factor for stroke, which is commonly asymptomatic, particularly in older patients, and often undetected until cardiovascular events occur. Development of novel technology has helped to improve detection of AF. However, the longer-term benefit of sy...
Autores principales: | Ellins, Elizabeth A, Wareham, Kathie, Harris, Daniel E, Hanney, Matthew, Akbari, Ashley, Gilmore, Mark, Barry, James P, Phillips, Ceri J, Gravenor, Michael B, Halcox, Julian P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187779/ https://www.ncbi.nlm.nih.gov/pubmed/37205320 http://dx.doi.org/10.1093/ehjopen/oead047 |
Ejemplares similares
-
Single-lead ECGs (AliveCor) are a feasible, cost-effective and safer alternative to 12-lead ECGs in community diagnosis and monitoring of atrial fibrillation
por: Bray, Jonathan James Hyett, et al.
Publicado: (2021) -
Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results
por: Goldenthal, Isaac L., et al.
Publicado: (2019) -
Effectiveness of a single lead AliveCor electrocardiogram application for the screening of atrial fibrillation: A systematic review
por: Hall, Angela, et al.
Publicado: (2020) -
Improving the utility and sustainability of novel health technology to improve clinical outcomes for patients: an East Staffordshire experience of screening for atrial fibrillation with the AliveCor KardiaMobile
por: Mathew, Savio, et al.
Publicado: (2021) -
Atrial fibrillation and heart failure- results of the CASTLE-AF trial
por: Shah, Syed Raza, et al.
Publicado: (2018)